Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain NVAX message board posts where the ticker symbol NVAX has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest NVAX SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-030109 Size: 5 KB
2018-05-15
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-030108 Size: 4 KB
2018-05-15
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-030107 Size: 4 KB
2018-05-15
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001144204-18-027138 (34 Act)  Size: 101 KB
2018-05-10 000-26770
18822785
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001144204-18-026676 (34 Act)  Size: 3 MB
2018-05-09 000-26770
18818786
DEFA14A  Documents Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Acc-no: 0001144204-18-023872 (34 Act)  Size: 419 KB
2018-04-30 000-26770
18790058
DEF 14A  Documents Other definitive proxy statements
Acc-no: 0001144204-18-023867 (34 Act)  Size: 3 MB
2018-04-30 000-26770
18790024
8-K  Documents Current report, items 1.01, 8.01, and 9.01
Acc-no: 0001144204-18-020525 (34 Act)  Size: 290 KB
2018-04-13 000-26770
18754768
424B5  Documents Prospectus [Rule 424(b)(5)]
Acc-no: 0001144204-18-020512 (33 Act)  Size: 483 KB
2018-04-13 333-222365
18754585
424B5  Documents Prospectus [Rule 424(b)(5)]
Acc-no: 0001144204-18-020137 (33 Act)  Size: 479 KB
2018-04-11 333-222365
18750211
More NVAX SEC Filings


Related news from
Tue, 22 May 2018
11:00:00 +0000
Free Technical Insights on OPKO Health and Three Other Biotech Stocks
Stock Research Monitor: NBIX, NVAX, and ONTX LONDON, UK / ACCESSWIRE / May 22, 2018 / If you want a free Stock Review on OPK sign up now at www.wallstequities.com/registration . On Monday, benchmark US ...
Thu, 17 May 2018
10:33:00 +0000
3 Top Stocks Under $5
These low-priced stocks could generate huge returns. But there are huge risks, too.
Wed, 16 May 2018
15:52:41 +0000
Edited Transcript of NVAX earnings conference call or presentation 9-May-18 8:30pm GMT
Q1 2018 Novavax Inc Earnings Call
Fri, 11 May 2018
13:10:00 +0000
Top 3 Healthcare Penny Stocks for 2018
The healthcare industry can be precarious for stocks of large companies, much less penny stocks. Of course, small-cap healthcare companies can be nudged out of the market by big competitors, and they can simply become unable to service debt when products and services don't sell quickly enough. None of these are new companies – they have made progress in developing products and finding the marketing outlets that are needed to sustain them.
Wed, 09 May 2018
23:06:52 +0000
Novavax: 1Q Earnings Snapshot
On a per-share basis, the Gaithersburg, Maryland-based company said it had a loss of 14 cents. The results met Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment ...
Wed, 09 May 2018
20:06:01 +0000
Novavax Reports First Quarter 2018 Financial Results
GAITHERSBURG, Md., May 09, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced its financial results for the first quarter ended March 31, 2018. First Quarter and Subsequent Achievements: ...
Mon, 07 May 2018
11:02:01 +0000
Novavax Reaches Significant Enrollment Milestone in the Prepare(TM) Phase 3 Trial of its RSV F Vaccine
Novavax, Inc. (NVAX) today announced it has reached a significant milestone in the Prepare(TM) Phase 3 clinical trial of its respiratory syncytial virus F protein recombinant nanoparticle vaccine (RSV F Vaccine) for infants via maternal immunization. Prepare is a global, pivotal Phase 3 clinical trial of the RSV F Vaccine, in healthy, third trimester pregnant women, which initiated in December 2015. "Reaching this enrollment target for the Prepare trial is a significant milestone in the advancement of our RSV F Vaccine franchise," said Stanley C. Erck, President and CEO of Novavax, Inc. "RSV remains an urgent global unmet medical need due to the mortality and morbidity associated with RSV disease in infants and the absence of a vaccine to prevent such disease.
Sun, 06 May 2018
11:07:27 +0000
Will Novavax Inc’s (NASDAQ:NVAX) Earnings Grow In The Years Ahead?
Novavax Inc’s (NASDAQ:NVAX) released its most recent earnings update in December 2017, which indicated that losses became smaller relative to the prrior year’s level – great news for investors TodayRead More...
Thu, 03 May 2018
05:00:04 +0000
Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 9, 2018
GAITHERSBURG, Md., May 02, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its first quarter 2018 financial and operating results following the close of U.S. financial ...
Mon, 30 Apr 2018
13:30:00 +0000
3 Stocks That Could Put Amazon's Returns to Shame
Investors looking for the next Amazon should consider an e-commerce facilitator, a vaccine developer, and a supplier of autonomous car parts.
Thu, 26 Apr 2018
14:25:02 +0000
Has Novavax (NVAX) Outpaced Other Medical Stocks This Year?
Is Novavax, Inc. (NVAX) Outperforming Other Medical Stocks This Year?
Mon, 23 Apr 2018
18:00:00 +0000
Don't Get Greedy With Novavax, Inc. Stock
Novavax's abysmal track record should be a huge red flag for potential shareholders.
Thu, 19 Apr 2018
13:35:00 +0000
3 Biotech Stocks That Will Thrive Amid Market Instability
The U.S. stock market is facing a severe volatility since the last couple of months despite a strong start this year. This downside can mainly be attributable to a potentially damaging trade war between the world’s two largest economies, United States and China, since this February.Source: Shutterstock
Tue, 17 Apr 2018
10:33:00 +0000
Buy Novavax After Its Latest Pullback?
Novavax has a couple of promising experimental vaccines. But could even more dilution be around the corner?
Mon, 16 Apr 2018
20:06:02 +0000
Novavax Announces Closing of Public Offering
GAITHERSBURG, Md., April 16, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biotechnology company committed to delivering novel products to prevent infectious diseases, today announced ...
Fri, 13 Apr 2018
12:20:00 +0000
Today’s Research Reports on Stocks to Watch: Novavax and Pfizer
NEW YORK, NY / ACCESSWIRE / April 13, 2018 / Novavax shares crumbled on Thursday after the company sold 30.3 million shares of common stock to the public at a lower price than what the stock closed on ...



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "VF is the place to be to pick up on new and proven investment ideas." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards